These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 26120866)
1. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature. Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866 [TBL] [Abstract][Full Text] [Related]
2. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis. Miyagawa I; Nakayamada S; Saito K; Hanami K; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016 [TBL] [Abstract][Full Text] [Related]
3. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373 [TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever. Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S Rheumatology (Oxford); 2015 Mar; 54(3):564-5. PubMed ID: 25504961 [No Abstract] [Full Text] [Related]
5. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Nakamura T; Kumon Y; Hirata S; Takaoka H Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698 [TBL] [Abstract][Full Text] [Related]
6. AA amyloidosis - Benefits and prospects of IL-6 inhibitors. Okuda Y Mod Rheumatol; 2019 Mar; 29(2):268-274. PubMed ID: 30132351 [TBL] [Abstract][Full Text] [Related]
7. AA amyloidosis treated with tocilizumab: case series and updated literature review. Courties A; Grateau G; Philippe P; Flipo RM; Astudillo L; Aubry-Rozier B; Fabreguet I; Fahd W; Fain O; Guggenbuhl P; Hachulla E; Papo T; Richez C; Sibilia J; Morel J; Berenbaum F; Sellam J; Amyloid; 2015; 22(2):84-92. PubMed ID: 25585627 [TBL] [Abstract][Full Text] [Related]
8. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Okuda Y; Takasugi K Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531 [TBL] [Abstract][Full Text] [Related]
9. Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis. Almenara-Tejederas M; Alonso-García F; Aguillera-Morales WA; de la Prada-Álvares F; Salgueira-Lazo M Nefrologia (Engl Ed); 2022; 42(1):28-32. PubMed ID: 36153896 [TBL] [Abstract][Full Text] [Related]
10. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever. Ugurlu S; Hacioglu A; Adibnia Y; Hamuryudan V; Ozdogan H Orphanet J Rare Dis; 2017 May; 12(1):105. PubMed ID: 28558744 [TBL] [Abstract][Full Text] [Related]
11. Natural history and outcome in systemic AA amyloidosis. Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117 [TBL] [Abstract][Full Text] [Related]
12. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature. Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992 [TBL] [Abstract][Full Text] [Related]
13. AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab. Hočevar A; Lestan B; Šemrl SS; Lakota K; Kojc N; Potočnik N; Tomšič M Amyloid; 2013 Dec; 20(4):275-6. PubMed ID: 24106820 [TBL] [Abstract][Full Text] [Related]
14. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab. Serelis J; Christaki S; Skopouli FN Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S169. PubMed ID: 25572486 [No Abstract] [Full Text] [Related]
17. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report . Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172 [TBL] [Abstract][Full Text] [Related]
18. Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports. Fukuda M; Sawa N; Hoshino J; Ohashi K; Motoaki M; Ubara Y Clin Nephrol; 2021 Jan; 95(1):54-61. PubMed ID: 33155543 [TBL] [Abstract][Full Text] [Related]
19. Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report. Seneschall C; Law S; Roufosse C; Woodham S; Kousios A J Nephrol; 2024 May; 37(4):1147-1152. PubMed ID: 38206475 [TBL] [Abstract][Full Text] [Related]
20. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review. Giannese D; Ferro F; Moriconi D; Bonadio AG; Elefante E; Egidi MF; Cupisti A; Baldini C CEN Case Rep; 2021 Feb; 10(1):23-29. PubMed ID: 32681397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]